COMBINATION TREATMENT WITH HBV-TARGETING GALNAC-siRNA AND SMALL-MOLECULE PD-L1 INHIBITOR INCREASES HBV-SPECIFIC IMMUNE RESPONSES IN A CHRONIC HEPATITIS B INFECTION MOUSE MODEL

HEPATOLOGY(2022)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要